Clinical Trials Microdosing Patients Treatment 
CannaMD
SEPTEMBER 9, 2020
Published only recently, in May of 2020, this clinical trial is the first to show that microdoses of cannabis can be just as effective as much higher doses. What is microdosing? The concept of microdosing is pretty simple. The premise behind marijuana microdosing is equally straightforward. Translation?
Cannabis Law Report
JULY 25, 2022
million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). The state agency grant funding followed the successful completion of a phase 1 clinical trial in 80 healthy participants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 10, 2022
Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Both Colorado and Oregon allow patients to take psilocybin under the supervision of regulated and licensed “healing centers.”
The Cannigma
DECEMBER 12, 2022
Using integration or psychotherapy along with these medicines allows patients to incorporate the positive effects permanently. What is microdosing? A microdose is a dose that does not elicit a perceivable intoxicating or trip-like effect. Microdosing is possible in theory, but there are no current recommendations.
Cannabis Law Report
SEPTEMBER 10, 2019
Upcoming studies will determine the effectiveness of psilocybin as a new therapy for opioid addiction, Alzheimer’s disease, post-traumatic stress disorder (PTSD), post-treatment Lyme disease syndrome (formerly known as chronic Lyme disease), anorexia nervosa and alcohol use in people with major depression. Mushrooms as Medicine?
Cannabis Law Report
MARCH 3, 2022
The team at Microdose, the world’s biggest medical psychedelic conference , said the country’s move to permit Med Plant Science Ltd to produce psychedelic compounds makes it the first country to legalize all psychedelic medicine. . The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.
Expert insights. Personalized for you.
111 
Let's personalize your content